“…The Extracorporeal Life Support Organization (ELSO) defines ECPR as the application of rapidly-deployed veno-arterial extracorporeal membrane oxygenation (ECMO) in patients in whom conventional CPR is unsuccessful in achieving sustained return of spontaneous circulation (ROSC) 3 . As Voicu et al (2022) pointed out in a most recent review article, the indications, timing and outcomes for ECLS in cardiotoxic poisoning – least to say the role of ECPR in poisoning-induced cardiac arrest – remain speculative due to the limited data, heterogeneity and multi-drug nature of most poisonings, and the fact that conducting randomized human trials is virtually impossible 4 .…”